Education and Specialization

Experience

Courses and Certifications

Professional Memberships

Awards

2020 - 10th International Gastrointestinal Cancers Virtual Conference 2-6 December A rare metastasis case: BRAF V600 Mutation Positive Gastrointestinal Stromal Tumor with Breast Metastasis (En iyi poster ödülü)

2022 - 20th Western Europe Masterclass in Medical Oncology, İspanya (Ölçme ve değerlendirme testi 1.’lik ödülü

2022 – Türk Tıbbi Onkoloji Derneği, Tıbbi Onkoloji Yeterlilik Belgesi (3.’lük ödülü)

2023 – ESMO Examination Certificate (En yüksek performans gösterenler listesi)

Research and Publications

2021 - 11th International Gastrointestinal Cancer Conference December 2 - 5, 2021, Istanbul                  Oral Presentation: Evaluation of the impact of preoperative sarcopenia  on treatment results and survival in patients with pancreatic cancer

2021 - 11th International Gastrointestinal Cancer Conference December 2 - 5, 2021, Istanbul                  Oral Presentation: Evaluation of gastrointestinal cancer patients  radiologically-diagnosed with sinusoidal obstruction syndrome: Single-Center Experience

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Aktas BY, Taban H, Aksoy S. N Engl J Med. 2019 Mar 7;380(10):985-986. doi: 10.1056/NEJMc1900150.                                                                 

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design. Guven DC, Guner G, Aktas BY, Aktepe OH, Taban H, Arik Z. Clin Colorectal Cancer. 2020 Sep;19(3):e71-e72. doi: 10.1016/j.clcc.2020.02.011. Epub 2020 Mar 6.

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors. Guven DC, Sahin TK, Aksun MS, Taban H, Aktepe OH, Aksu NM, Akkaş M, Erman M, Kilickap S, Dizdar O, Aksoy S. Support Care Cancer. 2020 Aug 26. doi: 10.1007/s00520-020-05702-8. Online ahead of print.    

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, Yıldız B, Yıldırım N, Demirci U, Sendur MA, Utkan G, Kılıckap S, Cicin I, Karadurmus N, Ürün Y. J Oncol Pharm Pract. 2020 Jul;26(5):1110-1116. doi: 10.1177/1078155219883004. Epub 2019 Oct 25.

Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study). Hizal M, Sendur MA, Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Taban H, Kucukarda A, Erturk I, Bilgin B, Yıldırım N, Demirci U, Kılıckap S, Cicin I, Karadurmus N, Yalcin B, Ürün Y. J Oncol Pharm Pract. 2020 Oct;26(7):1583-1589. doi: 10.1177/1078155219900908. Epub 2020 Feb 13.                                                                            

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer. C Guven D, Kilickap S, Guner G, Taban H, Dizdar O. J Oncol Pharm Pract. 2020 Jan;26(1):256-258. doi: 10.1177/1078155219877234. Epub 2019 Sep 29.

PILE: a candidate prognostic score in cancer patients treated with immunotherapy. Guven DC, Yildirim HC, Bilgin E, Aktepe OH, Taban H, Sahin TK, Cakir IY, Akin S, Dizdar O, Aksoy S, Yalcin S, Erman M, Kilickap S. Clin Transl Oncol. 2021 Aug;23(8):1630-1636. doi: 10.1007/s12094-021-02560-6. Epub 2021 Feb 14. PMID: 33586122.

Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors. Guven DC, Aktepe OH, Taban H, Aktas BY, Guner G, Yildirim HC, Sahin TK, Aksun MS, Dizdar O, Aksoy S, Erman M, Yalcin S, Kilickap S. Biomark Med. 2021 Sep;15(13):1123-1130. doi: 10.2217/bmm-2020-0674. Epub 2021 Aug 16. PMID: 34397271.

Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma. Aktepe OH, Güner G, Güven DC, Taban H, Yıldırım HÇ, Şahin TK, Ardıç FS, Yeter HH, Yüce D, Erman M. Turk J Urol. 2021 Mar;47(2):113-119. doi: 10.5152/tud.2021.20377. Epub 2021 Mar 1. PMID: 33819441; PMCID: PMC8018802.

Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Yekedüz E, Ertürk İ, Tural D, Karadurmuş N, Karakaya S, Hızal M, Arıkan R, Arslan Ç, Taban H, Küçükarda A, Öztaş NŞ, Sever ÖN, Uçar G, Can O, Şendur MA, Demirci U, Kılıçkap S, Çiçin İ, Öksüzoğlu B, Özgüroğlu M, Ürün Y. Future Oncol. 2021 Dec;17(35):4861-4869. doi: 10.2217/fon-2021-0717. Epub 2021 Nov 2. PMID: 34726480.

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Guven DC, Aksun MS, Sahin TK, Aktepe OH, Yildirim HC, Taban H, Ceylan F, Kertmen N, Arik Z, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Erman M. Support Care Cancer. 2021 Sep;29(9):5417-5423. doi: 10.1007/s00520-021-06139-3. Epub 2021 Mar 11. PMID: 33709186.

Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Guven DC, Taban H, Dizdar O. J Oncol Pharm Pract. 2022 Jan;28(1):203-204. doi: 10.1177/10781552211045909. Epub 2021 Oct 9. PMID: 34628993.

Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience. Diker O, Aktas BY, Ak R, Koylu B, Bas O, Taban H, Guven DC, Olgun P, Kertmen N, Dizdar O, Oksuzoglu B, Aksoy S. Future Oncol. 2022 Jan;18(3):323-331. doi: 10.2217/fon-2021-0303. Epub 2021 Nov 11. PMID: 34758639.

Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report. Taban H, Guven DC, Kılıçkap S. Cureus. 2022 Aug 9;14(8):e27828. doi: 10.7759/cureus.27828. PMID: 36106272; PMCID: PMC9452052

Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease. Yildirim HC, Guven DC, Aktepe OH, Taban H, Yilmaz F, Yasar S, Aksoy S, Erman M, Kilickap S, Yalcin S. J Clin Med. 2022 Sep 1;11(17):5171. doi: 10.3390/jcm11175171. PMID: 36079101; PMCID: PMC9457309.

Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience. Demir M, Güven D, Aktaş BY, Güner G, Aktepe OH, Taban H, Karakaş Y, Kılıçkap S, Kars A, Türker A, Dizdar Ö. South Asian J Cancer. 2022 Nov 14;11(4):287-292. doi: 10.1055/s-0042-1755467. eCollection 2022 Oct. PMID: 36756104

The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients. Özdede M, Taban H, Akman O, Önder S, Kılıçkap S. Cureus. 2023 Aug 24;15(8):e44016. doi: 10.7759/cureus.44016. eCollection 2023 Aug. PMID: 37746394

Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer. Ceylan F, Guven DC, Taban H, Aktepe O, Sahin TK, Kilickap S, Turker A, Hamaloglu E, Karakoc D, Isik A, Akyol A, Yalcin S, Dizdar O. Clin Res Hepatol Gastroenterol. 2023 Mar;47(3):102091. doi: 10.1016/j.clinre.2023.102091. Epub 2023 Feb 3. PMID: 36738855

Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Efil SC, Guner G, Guven DC, Celikten B, Celebiyev E, Taban H, Akyol A, Isik A, Kilickap S, Yalcin S, Dizdar O. Clin Res Hepatol Gastroenterol. 2023 Aug;47(7):102171. doi: 10.1016/j.clinre.2023.102171. Epub 2023 Jun 21. PMID: 37352926